kalmente ninasprei, suspensioon
zentiva k.s. - mometasoon - ninasprei, suspensioon - 50mcg 1mõõtannus 140mõõtannus 1tk; 50mcg 1mõõtannus 60mõõtannus 1tk
elmetacin spray nahasprei, lahus
stada baltics uab - indometatsiin - nahasprei, lahus - 8mg 1ml 50ml 1tk
propomitor süste-/infusiooniemulsioon
orion corporation - propofool - süste-/infusiooniemulsioon - 10mg 1ml 50ml 1tk; 10mg 1ml 100ml 1tk; 10mg 1ml 20ml 1tk; 10mg 1ml 20ml 5tk
rennie orange närimistablett
bayer uab - kaltsiumkarbonaat+magneesiumkarbonaat - närimistablett - 680mg+80mg 84tk; 680mg+80mg 48tk; 680mg+80mg 12tk; 680mg+80mg 60tk; 680mg+80mg 120tk; 680mg+80mg 36tk; 680mg+80mg 24tk
telexer kõvakapsel
gedeon richter plc. - dabigatraaneteksilaat - kõvakapsel - 150mg 180tk
telexer kõvakapsel
gedeon richter plc. - dabigatraaneteksilaat - kõvakapsel - 110mg 30tk; 110mg 60tk
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosupressandid - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosuppressants, valikuline immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
terebyo õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - teriflunomiid - õhukese polümeerikattega tablett - 14mg 84tk; 14mg 28tk
tifay õhukese polümeerikattega tablett
stada arzneimittel ag - teriflunomiid - õhukese polümeerikattega tablett - 14mg 28tk; 14mg 84tk